Tempted by a free trip for two?

Article

Tempted?

As we close the door on another eventful year, we thought it would be a good idea to reflect on some of those events that shaped your industry over the past 12 months.

It's easy to forget precisely what announcement or what new launch or revelation caught your attention this year and, perhaps, was a catalyst for a change in the way you practice. 2007 marked another year of exciting developments in ophthalmology. By speaking with some experts in your industry, we have attempted to gauge exactly what impact certain events and announcements actually had on European ophthalmology.

Read one of this month's feature articles to find out why Dr Jorge Alió believes the days of the multifocal IOL are numbered. Alternatively, hear Professor Albert Augustin's opinions on anti-VEGF therapy pricing or, if glaucoma is your field of interest, read Dr André Mermoud and Dr Tarek Shaarawy's thoughts on the issues affecting glaucoma practice in Europe today.

This month, we are also announcing the launch of a competition, which could see you, along with a partner, win FREE travel and accommodation to Berlin in time for next September?s ESCRS congress. In order to enter, simply renew your FREE subscription to Ophthalmology Times Europe by completing one of the forms within this issue, or go online and register at www.oteurope.com

Best of luck!

In the meantime, I would like to thank you all for your continued and valued support throughout 2007. It has been a real pleasure to serve you and to work with you, and I look forward to another great year.

Happy holidays.

Very best wishes,

Fedra Pavlou

fpavlou@advanstar.com



Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.